Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting

Journal of the American College of Cardiology

Volumn 36, Issue 7, 2000, Pages 2168-2173

  Kastrati, Adnan ^a,e   Koch, Werner ^a   Berger, Peter B ^b   Mehilli, Julinda ^a   Stephenson, Katherine ^c   Neumann, Franz Josef ^a   Von Beckerath, Nicolas ^a   Böttiger, Corinna ^a   Duff, Gordon W ^d   Schömig, Albert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MAYO CLINIC   (United States)

^c Interleukin Genetics Inc   (United States)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR;

ADULT; AGED; ALLELISM; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY STENT; EXTRACELLULAR MATRIX; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION;

AGED; CORONARY DISEASE; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; RECURRENCE; SIALOGLYCOPROTEINS; STENTS;

EID: 0033666905     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01014-7     Document Type: Article

References (26)

1. Atherosclerosis - An inflammatory disease
2. Cytokines and anti-cytokines
3. Interleukin-1 receptor antagonist: Role in biology
4. Interleukin 1: A mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids
5. Interleukin 1: The first interleukin
6. A cascade model for restenosis: A special case of atherosclerosis progression
7. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia
8. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist
9. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment
10. Cytokine production by normal human monocytes: Intersubject variation and relationship to an IL-1 receptor antagonist (IL-1ra) gene polymorphism
11. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes
12. Monokine antagonism is reduced in patients with IDDM
13. Cytokines as genetic modifying factors in immune and inflammatory diseases
14. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease
15. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
16. Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement
17. Predictive factors of restenosis after coronary stent placement
18. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions
19. Pl(A) polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement
20. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression: Evidence of inflammatory responses in coronary angioplasty
21. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment
22. Arterial inflammation in mice lacking the interleukin-1 receptor antagonist gene
23. Effect of interleukin-1 receptor antagonist on vascular smooth muscle cell proliferation
24. Monocyte cytokine production in an elderly population: Effect of age and inflammation
25. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist genes
26. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers